Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
N-butyl–3–{[6–(9H–purin–6–ylamino)hexanoyl]amino}benzamide is a synthetic small molecule belonging to the class of acylanilide and benzamide derivatives, specifically acylanilobenzoic acid derivatives. It features a purine moiety linked via a hexanoylamide chain to a substituted benzamide core. The compound has not been approved for any clinical use and there are no known indications or clinical trials associated with it. Its mechanism of action, biological targets, and therapeutic potential remain uncharacterized in the public domain. No developer or manufacturer is currently associated with this molecule, and it does not appear in regulatory drug approval databases as of June 2025[1][4][5][7].
- Other names
- N-butyl-3-[6-(9H-purin-6-ylamino)hexanamido]benzamideN-butyl-3-{[6-(3H-purin-6-ylamino)hexanoyl]amino}benzamideBenzamide, N-butyl-3-[1-oxo-6-(9H-purin-6‑ylamino)hexyl]amino-3-(6-(9H-purin‑6‑ylamino)hexanamido)-N-butylbenzamide
Beyond the preview
Go deeper on N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide.